April 2024: NEI Member News and CME/CE Releases

NEI Members have exclusive access to practical point-of-care resources and an extensive library of online content, all designed to help you stay current in your clinical practice. Not yet an NEI Member? Join now to gain this valuable resource.

Highlights from 2024 NEI Synapse

The 2024 NEI Synapse took place April 19-21, 2024 in Las Vegas, Nevada and Virtually. The 3-day event was filled with presentations on cutting-edge research and treatment advances, brilliant faculty, and spirited networking with over 1,000 attendees. Below are featured session highlights:

We Didn’t Write the Rx: A Guide to the Pros and Cons of Complementary and Alternative Medicine

Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease

The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression

Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan

NEI Member Tips and Pearls provides highlights and updated prescribing information for key psychotropic treatments.

>> Clonidine

16-Year-Old Adolescent with Depressive Symptoms, Amotivation, and Cannabis Use (case study, CME/CE)*

Preventing Relapse in Schizophrenia with Antipsychotic Maintenance Treatment (video snippet, CME/CE)*

*Counts toward the Master Psychopharmacology Program requirements.

Newly released NEI Members-only Encore Presentations from the 2023 NEI Congress:

Lithium 101: Hit the Road Jack If You Don't Know About ENaC

The Other Meds: Nonstimulant Treatment Options for ADHD

NEI Prescribe is included with your NEI Membership. 23 additional medications have been added to the Child and Adolescent section of NEI Prescribe! Make sure you keep the app up to date on your mobile device or download today

What Kinds of Patient Resources Are Available to NEI Members?

Patient Medication Guides

• Handouts with trusted information, easy-to-read layout, and options for patient-centered personalization.

NEI Membership gives you exclusive access to practical point-of-care resources, an extensive library of online content, and significant discounts on registration to our annual conferences, all designed to help you stay current in your clinical practice.

Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding

Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia

TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

>> View additional articles